INOZYME PHARMA, INC. Lessee, Operating Lease, Liability, to be Paid, Year Four
INOZYME PHARMA, INC. had Lessee, Operating Lease, Liability, to be Paid, Year Four of $0 as of 2022-12-31, per its 10-K filed 2023-03-22.
Discontinued › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour · last filed 2023-03-22
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Four $0.00.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Four $944.00K.
- 2021-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Four $944.00K.
- 2021-06-30: Lessee, Operating Lease, Liability, to be Paid, Year Four $944.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Four |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-22 |
| 2021-12-31 | $944.00K 10-K · filed 2022-03-15 |
| 2021-09-30 | $944.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $944.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $944.00K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $1.02M 10-K · filed 2021-03-25 |
| 2020-09-30 | $1.02M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.02M 10-Q · filed 2020-09-03 |